ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
- DOI
- 10.1158/2159-8290.cd-25-0960
- Published
- 2026 Jun 1
- Container
- Cancer discovery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2159-8290.cd-25-0960,
title = {ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.},
author = {Piotrowska Z and Ahn MJ and Voon PJ and Pang YK and How SH and Kim SW and Cortinovis D and de Castro Carpeño J and Tiseo M and Rodríguez Abreu D and Ramalingam SS and Li J and Servidio L and Taylor R and Hartmaier R and Markovets AA and Tang KH and Cho BC},
year = {2026},
journal = {Cancer discovery},
doi = {10.1158/2159-8290.cd-25-0960},
url = {https://doi.org/10.1158/2159-8290.cd-25-0960}
}RIS
TY - JOUR TI - ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib. AU - Piotrowska Z AU - Ahn MJ AU - Voon PJ AU - Pang YK AU - How SH AU - Kim SW AU - Cortinovis D AU - de Castro Carpeño J AU - Tiseo M AU - Rodríguez Abreu D AU - Ramalingam SS AU - Li J AU - Servidio L AU - Taylor R AU - Hartmaier R AU - Markovets AA AU - Tang KH AU - Cho BC PY - 2026 JO - Cancer discovery DO - 10.1158/2159-8290.cd-25-0960 UR - https://doi.org/10.1158/2159-8290.cd-25-0960 ER -
APA
Z, P., MJ, A., PJ, V., YK, P., SH, H., SW, K., D, C., J, D. C. C., M, T., D, R. A., SS, R., J, L., L, S., R, T., R, H., AA, M., KH, T., & BC, C. (2026). ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.. Cancer discovery. https://doi.org/10.1158/2159-8290.cd-25-0960
Source records
- pubmed · retrieved 2026-09-26T05:42:34.365Z